PREMARIN

This brand name is authorized in Brazil, Canada, Hong Kong, Ireland, Japan, Malta, Mexico, New Zealand, Singapore, United Kingdom, United States

Active ingredients

The drug PREMARIN contains one active pharmaceutical ingredient (API):

1 Estrogens, conjugated
UNII IU5QR144QX - ESTROGENS, CONJUGATED

The active ingredients of conjugated estrogens are primarily the sulfate esters of estrone, equilin sulfates, 17α-estradiol and 17β-estradiol. These substitute for the loss of estrogen production in menopausal women, and alleviate menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy.

Read about Estrogens, conjugated

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
PREMARIN Powder for solution for injection FDA, National Drug Code (US) MPI, US: SPL/Old
PREMARIN Coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
PREMARIN Film-coated tablet FDA, National Drug Code (US) MPI, US: SPL/PLR
PREMARIN Vaginal cream FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
G03CA57 Conjugated estrogens G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03C Estrogens → G03CA Natural and semisynthetic estrogens, plain
Discover more medicines within G03CA57

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 522719120082407, 522719120082507
Country: CA Health Products and Food Branch Identifier(s): 02043386, 02043440, 02414678, 02414686, 02414694
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 114769, 26873, 26881, 336714
Country: HK Department of Health Drug Office Identifier(s): 29753, 29754, 29755, 29759
Country: IE Health Products Regulatory Authority Identifier(s): 62063, 62071
Country: JP 医薬品医療機器総合機構 Identifier(s): 2479004F1033
Country: MT Medicines Authority Identifier(s): AA565/22704
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 31395, 44321
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 587, 588
Country: SG Health Sciences Authority Identifier(s): 03229P, 04484P, 04706P
Country: US FDA, National Drug Code Identifier(s): 0046-0749, 0046-0872, 0046-1100, 0046-1101, 0046-1102, 0046-1103, 0046-1104, 50090-0167

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.